Merck & Co., Inc. Share Price

Equities

MRK

US58933Y1055

Pharmaceuticals

Delayed Nyse 01:27:11 11/05/2024 am IST 5-day change 1st Jan Change
130.1 USD -0.12% Intraday chart for Merck & Co., Inc. +2.19% +19.52%
Days
Hours
Minutes
Seconds
-40%
on all our subscriptions*
Last Days!
Take advantage of the offer
* See conditions on site
Sales 2024 * 64.11B 5,351B Sales 2025 * 68.6B 5,726B Capitalization 330B 27,534B
Net income 2024 * 19.51B 1,629B Net income 2025 * 22.27B 1,859B EV / Sales 2024 * 5.44 x
Net Debt 2024 * 18.91B 1,579B Net Debt 2025 * 7.6B 635B EV / Sales 2025 * 4.92 x
P/E ratio 2024 *
16.8 x
P/E ratio 2025 *
14.6 x
Employees 71,000
Yield 2024 *
2.38%
Yield 2025 *
2.51%
Free-Float 70.77%
More Fundamentals * Assessed data
Dynamic Chart
1 day+0.09%
1 week+1.54%
Current month+0.78%
1 month+2.78%
3 months+3.81%
6 months+27.20%
Current year+19.46%
More quotes
1 week
126.76
Extreme 126.76
131.51
1 month
124.50
Extreme 124.5
132.80
Current year
109.16
Extreme 109.16
133.10
1 year
99.14
Extreme 99.14
133.10
3 years
70.89
Extreme 70.89
133.10
5 years
65.25
Extreme 65.25
133.10
10 years
45.69
Extreme 45.69
133.10
More quotes
Managers TitleAgeSince
Chief Executive Officer 57 01/14/01
Director of Finance/CFO 55 01/90/01
Chief Tech/Sci/R&D Officer 55 01/20/01
Members of the board TitleAgeSince
Director/Board Member 63 27/07/27
Director/Board Member 67 01/15/01
Director/Board Member 69 01/18/01
More insiders
Date Price Change Volume
11/24/11 130.1 -0.12% 3 825 112
09/24/09 130.2 +0.52% 9,216,740
08/24/08 129.6 -0.64% 6,659,121
07/24/07 130.4 +2.20% 6,682,316
06/24/06 127.6 +0.05% 6,551,962

Delayed Quote Nyse, May 10, 2024 at 01:30 am IST

More quotes
Merck & Co., Inc. specializes in the development, production, and marketing of therapeutic products and vaccines sold under prescription. Net sales break down by activity as follows: - sale of pharmaceutical products (69.7%): for treating hypertension, osteoporosis, atherosclerosis, respiratory, bacterial and fungal, ophthalmologic, and urological diseases, acute migraine, hair loss in men, etc.; - sale of vaccines (18%); - sale of animal health products (9.4%); - other (2.9%). Net sales are distributed geographically as follows: the United States (45.9%), Europe/Middle East/Africa (24.5%), China (8.8%), Japan (6.1%), Asia/Pacific (6.1%), Latin America (4.3%) and other (4.3%).
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
B-
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
28
Last Close Price
130.2 USD
Average target price
141.6 USD
Spread / Average Target
+8.76%
Consensus
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
SIGN UP NOW